US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 128.460
  • -0.120-0.09%
Close Feb 26 16:00 ET
  • 129.680
  • +1.220+0.95%
Pre 04:16 ET
13.66BMarket Cap-178.42P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
41.08%-73.18M
-534.55%-13.08M
-4.97%-26.53M
101.47%542K
43.20%-34.12M
54.03%-124.2M
94.74%-2.06M
52.63%-25.27M
61.18%-36.8M
27.50%-60.07M
Net income from continuing operations
46.54%-74.68M
40.92%-16.89M
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
Depreciation and amortization
-3.79%508K
-19.85%109K
2.22%138K
4.88%129K
-1.49%132K
-19.51%528K
-4.90%136K
-20.59%135K
-28.49%123K
-21.64%134K
Other non cash items
-10.87%82K
-21.74%18K
-25.00%18K
0.00%23K
4.55%23K
2.22%92K
4.55%23K
9.09%24K
4.55%23K
-8.33%22K
Change In working capital
-82.90%-54.1M
-168.84%-9.67M
-20.37%-16M
138.35%2.09M
-22.73%-30.52M
49.12%-29.58M
283.44%14.04M
-10.61%-13.29M
76.79%-5.46M
-66.35%-24.87M
-Change in receivables
-35.16%-52.48M
-84.10%-20.89M
101.58%106K
-0.96%-14.56M
-169.65%-17.14M
29.44%-38.83M
16.87%-11.35M
53.95%-6.71M
-1.94%-14.42M
49.86%-6.36M
-Change in inventory
43.43%-14.91M
-53.19%-11.16M
-25.94%-1.37M
86.15%-1.88M
88.71%-499K
-64.96%-26.35M
-2,154.49%-7.28M
-176.56%-1.09M
20.87%-13.55M
-8,138.18%-4.42M
-Change in prepaid assets
-1,421.00%-67.79M
-237.97%-17.04M
-15.66%-18.95M
-176.93%-7.8M
-127.34%-24M
77.43%-4.46M
1,261.62%12.35M
-166.43%-16.39M
381.04%10.14M
-18.26%-10.56M
-Change in payables and accrued expense
97.60%81.54M
93.69%39.56M
-60.80%4.31M
112.11%26.44M
529.74%11.23M
28.77%41.26M
140.18%20.43M
51.03%10.99M
8.84%12.47M
-154.29%-2.61M
-Change in other current liabilities
62.14%-457K
-43.56%-145K
9.78%-83K
-26.67%-114K
87.55%-115K
-310.28%-1.21M
91.00%-101K
-4,500.00%-92K
-4.65%-90K
-151.79%-924K
Cash from discontinued investing activities
Operating cash flow
41.08%-73.18M
-534.55%-13.08M
-4.97%-26.53M
101.47%542K
43.20%-34.12M
54.03%-124.2M
94.74%-2.06M
52.63%-25.27M
61.18%-36.8M
27.50%-60.07M
Investing cash flow
Cash flow from continuing investing activities
-417.55%-335.15M
-416.08%-149.89M
-937.35%-209.2M
-91.80%7.77M
198.28%16.18M
182.21%105.54M
-5.65%47.42M
-119.00%-20.17M
154.50%94.75M
94.89%-16.46M
Net PPE purchase and sale
-19.70%-322K
42,800.00%427K
-159.70%-696K
----
----
65.42%-269K
-103.57%-1K
-129.06%-268K
----
----
Net investment purchase and sale
-416.44%-334.83M
-416.97%-150.32M
-947.83%-208.51M
-91.75%7.82M
198.28%16.18M
182.93%105.81M
-5.60%47.42M
-118.72%-19.9M
153.66%94.75M
94.88%-16.46M
Cash from discontinued investing activities
Investing cash flow
-417.55%-335.15M
-416.08%-149.89M
-937.35%-209.2M
-91.80%7.77M
198.28%16.18M
182.21%105.54M
-5.65%47.42M
-119.00%-20.17M
154.50%94.75M
94.89%-16.46M
Financing cash flow
Cash flow from continuing financing activities
3,086.46%567.51M
86.62%5.61M
160.91%6.73M
6,250.37%545.18M
174.42%9.99M
-96.09%17.81M
37.36%3M
-54.35%2.58M
55.98%8.59M
-99.18%3.64M
Net common stock issuance
--543.09M
--0
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
37.13%24.42M
86.62%5.61M
160.91%6.73M
-75.62%2.09M
174.42%9.99M
-16.93%17.81M
36.92%3M
-54.35%2.58M
55.98%8.59M
-55.00%3.64M
Cash from discontinued financing activities
Financing cash flow
3,086.46%567.51M
86.62%5.61M
160.91%6.73M
6,250.37%545.18M
174.42%9.99M
-96.09%17.81M
37.36%3M
-54.35%2.58M
55.98%8.59M
-99.18%3.64M
Net cash flow
Beginning cash position
-0.56%149.52M
360.75%466.06M
382.65%695.06M
82.72%141.57M
-0.56%149.52M
60.36%150.37M
-26.22%101.15M
83.13%144.01M
-40.72%77.48M
60.36%150.37M
Current changes in cash
18,871.34%159.18M
-425.37%-157.36M
-434.33%-228.99M
731.92%553.49M
89.10%-7.95M
-101.50%-848K
264.83%48.37M
-173.29%-42.86M
227.80%66.53M
-297.37%-72.89M
End cash Position
106.46%308.7M
106.46%308.7M
360.75%466.06M
382.65%695.06M
82.72%141.57M
-0.56%149.52M
-0.56%149.52M
-26.22%101.15M
83.13%144.01M
-40.72%77.48M
Free cash flow
40.95%-73.5M
-513.53%-12.65M
-6.59%-27.22M
101.33%489K
43.20%-34.12M
54.06%-124.47M
94.74%-2.06M
52.24%-25.54M
61.23%-36.8M
27.99%-60.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 41.08%-73.18M-534.55%-13.08M-4.97%-26.53M101.47%542K43.20%-34.12M54.03%-124.2M94.74%-2.06M52.63%-25.27M61.18%-36.8M27.50%-60.07M
Net income from continuing operations 46.54%-74.68M40.92%-16.89M-8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M
Depreciation and amortization -3.79%508K-19.85%109K2.22%138K4.88%129K-1.49%132K-19.51%528K-4.90%136K-20.59%135K-28.49%123K-21.64%134K
Other non cash items -10.87%82K-21.74%18K-25.00%18K0.00%23K4.55%23K2.22%92K4.55%23K9.09%24K4.55%23K-8.33%22K
Change In working capital -82.90%-54.1M-168.84%-9.67M-20.37%-16M138.35%2.09M-22.73%-30.52M49.12%-29.58M283.44%14.04M-10.61%-13.29M76.79%-5.46M-66.35%-24.87M
-Change in receivables -35.16%-52.48M-84.10%-20.89M101.58%106K-0.96%-14.56M-169.65%-17.14M29.44%-38.83M16.87%-11.35M53.95%-6.71M-1.94%-14.42M49.86%-6.36M
-Change in inventory 43.43%-14.91M-53.19%-11.16M-25.94%-1.37M86.15%-1.88M88.71%-499K-64.96%-26.35M-2,154.49%-7.28M-176.56%-1.09M20.87%-13.55M-8,138.18%-4.42M
-Change in prepaid assets -1,421.00%-67.79M-237.97%-17.04M-15.66%-18.95M-176.93%-7.8M-127.34%-24M77.43%-4.46M1,261.62%12.35M-166.43%-16.39M381.04%10.14M-18.26%-10.56M
-Change in payables and accrued expense 97.60%81.54M93.69%39.56M-60.80%4.31M112.11%26.44M529.74%11.23M28.77%41.26M140.18%20.43M51.03%10.99M8.84%12.47M-154.29%-2.61M
-Change in other current liabilities 62.14%-457K-43.56%-145K9.78%-83K-26.67%-114K87.55%-115K-310.28%-1.21M91.00%-101K-4,500.00%-92K-4.65%-90K-151.79%-924K
Cash from discontinued investing activities
Operating cash flow 41.08%-73.18M-534.55%-13.08M-4.97%-26.53M101.47%542K43.20%-34.12M54.03%-124.2M94.74%-2.06M52.63%-25.27M61.18%-36.8M27.50%-60.07M
Investing cash flow
Cash flow from continuing investing activities -417.55%-335.15M-416.08%-149.89M-937.35%-209.2M-91.80%7.77M198.28%16.18M182.21%105.54M-5.65%47.42M-119.00%-20.17M154.50%94.75M94.89%-16.46M
Net PPE purchase and sale -19.70%-322K42,800.00%427K-159.70%-696K--------65.42%-269K-103.57%-1K-129.06%-268K--------
Net investment purchase and sale -416.44%-334.83M-416.97%-150.32M-947.83%-208.51M-91.75%7.82M198.28%16.18M182.93%105.81M-5.60%47.42M-118.72%-19.9M153.66%94.75M94.88%-16.46M
Cash from discontinued investing activities
Investing cash flow -417.55%-335.15M-416.08%-149.89M-937.35%-209.2M-91.80%7.77M198.28%16.18M182.21%105.54M-5.65%47.42M-119.00%-20.17M154.50%94.75M94.89%-16.46M
Financing cash flow
Cash flow from continuing financing activities 3,086.46%567.51M86.62%5.61M160.91%6.73M6,250.37%545.18M174.42%9.99M-96.09%17.81M37.36%3M-54.35%2.58M55.98%8.59M-99.18%3.64M
Net common stock issuance --543.09M--0--0----------0--0--0--------
Proceeds from stock option exercised by employees 37.13%24.42M86.62%5.61M160.91%6.73M-75.62%2.09M174.42%9.99M-16.93%17.81M36.92%3M-54.35%2.58M55.98%8.59M-55.00%3.64M
Cash from discontinued financing activities
Financing cash flow 3,086.46%567.51M86.62%5.61M160.91%6.73M6,250.37%545.18M174.42%9.99M-96.09%17.81M37.36%3M-54.35%2.58M55.98%8.59M-99.18%3.64M
Net cash flow
Beginning cash position -0.56%149.52M360.75%466.06M382.65%695.06M82.72%141.57M-0.56%149.52M60.36%150.37M-26.22%101.15M83.13%144.01M-40.72%77.48M60.36%150.37M
Current changes in cash 18,871.34%159.18M-425.37%-157.36M-434.33%-228.99M731.92%553.49M89.10%-7.95M-101.50%-848K264.83%48.37M-173.29%-42.86M227.80%66.53M-297.37%-72.89M
End cash Position 106.46%308.7M106.46%308.7M360.75%466.06M382.65%695.06M82.72%141.57M-0.56%149.52M-0.56%149.52M-26.22%101.15M83.13%144.01M-40.72%77.48M
Free cash flow 40.95%-73.5M-513.53%-12.65M-6.59%-27.22M101.33%489K43.20%-34.12M54.06%-124.47M94.74%-2.06M52.24%-25.54M61.23%-36.8M27.99%-60.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+5.09%
NVIDIA
NVDA
+3.67%
Meta Platforms
META
+2.46%
Oracle
ORCL
+2.33%
Amazon
AMZN
+0.73%

Unlock the Full List